Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines.

Area of Science:

• Genetics
• Bioinformatics
• Medical Diagnostics

Background:

• The American College of Medical Genetics and Genomics/Association for Medical Pathology (ACMG/AMP) guidelines provide a qualitative framework for variant evaluation.
• Previous work demonstrated the compatibility of these guidelines with quantitative Bayesian methods.
• A need exists for a more accessible and quantifiable approach to variant interpretation.

Purpose of the Study:

• To develop a simplified, quantitative point system for evaluating Mendelian disease gene variants.
• To demonstrate that this point system recapitulates the established Bayesian formulation of the ACMG/AMP guidelines.
• To explore the strengths and limitations of a points-based approach for variant classification.

Main Methods:

• Abstracting ACMG/AMP "strength of evidence categories" into a quantifiable point system.
• Establishing proportionality between point values and Log(odds) of pathogenicity.
• Demonstrating the additive nature of points and their ability to mirror Bayesian outcomes.
• Analyzing the system's simplicity, calibration potential, and limitations regarding prior probabilities.

Main Results:

• The abstracted point system is proportional to Log(odds) and additive.
• The point system successfully recapitulates the Bayesian formulation of the ACMG/AMP guidelines.
• Strengths include simplicity and empirical calibration of evidence strength.
• Weaknesses involve a restricted range of prior probabilities and obscured Bayesian underpinnings.

Conclusions:

• A points-based system offers user-friendliness for variant interpretation.
• This system can be practically useful for Mendelian disease gene variant evaluation.
• Acknowledging the underlying Bayesian principles is crucial for accurate application of the point system.